Sleep Apnea Implants Market Forecast Report | Size & Share 2030

Coverage: Sleep Apnea Implants Market covers analysis By Product Type (Hypoglossal Neurostimulation Devices, Phrenic Nerve Stimulator, Others), Indication (Obstructive Sleep Apnea, Central Sleep Apnea), and by End User (Hospitals, ASCs, Others), Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America)

  • Report Code : TIPRE00030110
  • Category : Medical Device
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

The sleep apnea implants market size was US$ 311.24 million in 2022 and is expected to reach US$ 803.26 million by 2030; it is estimated to register a CAGR of 12.58% from 2022 to 2030. 

Market Insights and Analyst View:

A sleep apnea implant is a medical device that helps to breathe during sleep. The implant is also known as a hypoglossal nerve stimulator or upper airway stimulation device. The device is implanted in patients upper right chest beneath skin. Key factors driving the growth of sleep apnea implants market are rising prevalence of sleep deprivation disorders and advancements in the sleep apnea implant devices across various end users. However, the high cost of sleep apnea implants and complications associated with sleep apnea implantation may hinder the market growth.

Growth Drivers and Restraints:

Rising Prevalence of Sleep Deprivation Disorders

Sleep deprivation disorders such as obstructive sleep apnea is the most common type of sleep disorder that occurs when a patients airway becomes completely or partially blocked repeatedly because the soft tissue in the back of throat collapses during sleep. During these episodes, diaphragm and chest muscles work harder than normal to open airways. The rising consequences of sleep and sleep deprivation is common among those people who are working for longer hours. According to the data published in Journal of Clinical Medicine in 2021, the estimated prevalence of OSA in general population ranges from 2% and 50% of men and 2% and 23% of women. According to the data published by Lancet Respiratory Medicine Journal in 2019, disorder affects approximately 936 million people globally. Another data published in Progress in Orthodontics in 2021, alarming data has shown that the prevalence of OSA is expected to climb up to 23.4% for female adults and 49.7% for male adults. OSA is associated with increased risk of diseases such as, cardiovascular disease, hypertension, atrial fibrillation, and adverse social outcomes. Factors such as loss of productivity, increased risk of injury and motor vehicle accident, and behavioral change with significant morbildity, comorbidity and mortality.

Substantial surge in the number of sleep apnea patients is one of the major factor accelerating the growth of sleep apnea implants market. Moreover, the rising prevalence of sleep deprivation disorders has led to increased awareness related to tracking sleep patterns. Sleep-related awareness is contributing towards increased diagnosis rate of sleep disorders, and advancements in sleep apnea implant treatment thereby propelling the overall market growth of sleep apnea implants market.

Advancements in the Sleep Apnea Devices

The sleep apnea implants market is further driven by advancements in the sleep apnea implant devices. research studies demonstrating the technological advancements of sleep apnea implants are anticipated to boost market growth of sleep apnea implants over the forecast period. As per the article published in Progress in Orthodontics in February 2022, mini-implant assisted rapid palatal expansion (MARPE) has been used for patients with OSA. MARPE which helps to increase the size of the nasal and oral cavities and widens the midface, was found effective with 85% success rate along with respiratory benefits. Furthermore, companies in the sleep apnea implants market is also involved new technological developments for sleep apnea implants. For instance, in February 2022, LivaNova PLC demonstrated its investigational device exemption study, as the patient was implanted with the company's OSA treatment device i.e. LivaNova aura6000 System, which is an implantable hypoglossal neurostimulator used to treat adult patients with moderate to severe OSA. The company's randomized controlled study, “Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation” (OSPREY), has also demonstrated the safety and effectiveness of the LivaNova aura6000 System.

Additionally, favorable reimbursement scenario for sleep apnea devices and therapies and increasing number of campaigns being carried out to provide awareness related to the untreated sleep apnea such as OSA are expected to drive the demand for sleep apnea implants market. For instance, "More than a Snore" campaign by the American Academy of Sleep Medicine supported by the Academy by the Centers for Disease Control (CDC) and Prevention's National Center for Chronic Disease Prevention and Health Promotion.

Thus, all the aforementioned factors such as prevalence of sleep deprived disorders, technological advancements in sleep apnea implants, and favourable reimbursement scenario is anticipated to witness market growth over the forecast period.

Strategic Insights

Report Segmentation and Scope:

The sleep apnea implants market, by product, is segmented into hypoglossal neurostimulation devices, phrenic nerve stimulator and others. The hypoglossal neurostimulation devices segment held the largest market share in 2022. The segment is anticipated to register the highest CAGR from 2022 to 2030. The market growth of this segment can be attributed to increase in adoption of hypoglossal neurostimulation devices for sleep apnea treatment and rising availability of numbers of sleep apnea implants by key players. The sleep apnea implants market, by indication, is segmented into OSA and central sleep apnea. The OSA segment held the largest market share in 2022 and is expected to register the highest CAGR during 2022–2030. Rising application of sleep apnea implants, high number of sleeping disorders patients, surge in obese population is expected to propel the growth of the OSA market in the sleep apnea implants market.

The Sleep Apnea Implants market, based on geography, is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South and Central America (Brazil, Mexico, and the Rest of SCAM).

Segmental Analysis:

The Sleep Apnea Implants market, by product, is segmented into hypoglossal neurostimulation devices, phrenic nerve stimulator and others. The hypoglossal neurostimulation devices segment held the largest market share in 2022. The segment is anticipated to register the highest CAGR from 2022 to 2030. Increasing prevalence of sleep apnea disorders that requires treatment using neurostimulation device such as hypoglossal neurostimulation devices owing to its efficacy in management of obstructive sleep apnea and its effective mechanism for muscle stimulation. The hypoglossal nerve regulates the tongue movement and airway muscle, once it is stimulated, the nerve assists in maintaining open airway during sleep activity.

The sleep apnea implants market, by indication, is segmented into Obstructive Sleep Apnea (OSA) and central sleep apnea. The OSA segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. OSA is a disorder which includes stoppage and start of breathing during sleep, resulting in snoring. Increasing number of patients who are not treated by continuous positive airway pressure (CPAP) devices, and patients who suffer from OSA are adopting sleep apnea implants. Increasing number of patient population suffering from OSA has increased over the years. According to the data published in Journal of Clinical Sleep Medicine in 2021,  several prevalence studies were undertaken more than 15 years ago. A recent study has suggested increase in the prevalence of OSA in the general population attributed to more sensitive measurements. Such studies also suggested that the prevalence of OSA is increasing, many be due to ‘obesity epidemic’. Obesity is also another concern attributed towards sleep apnea implants and market growth.

Regional Analysis:

Based on geography, the global Sleep Apnea Implants market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2022, North America held the largest share of the global sleep apnea implants market size. Asia Pacific is estimated to register the highest CAGR from 2022 to 2030. North America sleep apnea implants market has experienced substantial growth in the past few years due to rising population of obese population undergoing sleep apnea implants and prevalence of OSA in North America and advancements in sleep apnea implants. Approximately, 5 million patients own CPAP machines in North America. A CPAP machine is being used for the treatment of sleep apnea. In addition, Asia-Pacific region is anticipated to record the fastest growth in the sleep apnea implants market, due to  the presence of companies involved in sleep apnea related clinical studies. For instance, in August 2022, StimAire Australia Pty Ltd. sponsored a clinical study to assess the change in Apnea-Hypopnea Index (AHI) using the StimAire Model S system. This system is intended to treat OSA by stimulating the hypoglossal nerve and includes a dedicated neurostimulator and a breathing sensor. The system will also be used in diagnosed patients with moderate to severe OSA.

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global sleep apnea implants market are listed below:

  1. In March 2019, Nyxoah SA declared the European CE mark approval for the Genio System for the treatment of obstructive sleep apnea.
  2. In August 2020, Inspire Medical Systems, Inc. declared that the Australian Therapeutic Goods Administration approved inspire system therapy for obstructive sleep apnea treatment.
  3. In February 2021, Zoll Medical Corporation, a subsidiary of Asahi Kasai Corporation has announced the acquisition of Respicardia, Inc., a medical device company that manufactures sleep apnea devices.
  4. In August 2021, Zoll Medical Corporation, an Asahi Kasei Company, received U.S. FDA approval for the remedy EL-X System for the treatment of central sleep apnea. 
  5. In June 2021, Inspire Medical Systems, Inc. sponsored a clinical study to analye the objective change in cognition and expressive language after implant and therapy using Inspire Upper Airway Stimulation (UAS) System.
  6. In April 2022, Inspire Medical Systems declared a $10 million minority equity investment in EnsoData, a Madison-based company. Company developed an FDA-approved sleep study analysis platform. This investment is expected to boost the Inspire Medical System's offerings in the sleep apnea market.
  7. In January 2023, NHS doctors began treating people with sleeping disorders using a sleep apnea implant that helps patients get a good sleep. The procedure involves implantation of device in the chest to prevent their breathing from stopping and starting.

Competitive Landscape and Key Companies:

Asahi Kasei Corporation, Avery biomedical, Inspire Medical Systems, Inc., LinguaFlex, Inc., LivaNova PLC, Medtronic plc, Nyxoah SA, Siesta Medical, SomnoMed, Somnowell are provided in this report. There are some important players in the market such as Inspire Medical Systems, Inc., Asahi Kasei Corporation, Medtronic plc and Nyxoah SA are a few key companies operating in the Sleep apnea implants   market. These companies adopt product innovation strategies to meet evolving customer demands, which allows them to maintain their brand name in the sleep apnea implants market.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
REGIONAL FRAMEWORK
World Geography
Strategic Insights

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS
medical-device
Research Criteria
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Sleep Apnea Implants Market